RyboDyn
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $10M
Investors
- 6
About RyboDyn
Founded in 2022 and based in California, US, RyboDyn, Inc. drug discovery company that delivers specialized proteomic solutions, particularly addressing challenges within the dark proteome. The company was founded by its President Corey Dambacher and Ashley Woodfin. In March 2026, RyboDyn, Inc. RyboDyn specializes in addressing complex challenges within proteomics with a focus on the dark proteome. The company offers solutions designed to explore previously difficult-to-analyze protein interactions and functions. The company’s primary offerings provide researchers and pharmaceutical companies with deeper insights into protein behavior, enhancing drug discovery and development processes. The firm's technologies caters end-users in academic research institutions, biotechnology firms, and pharmaceutical companies engaged in developing therapeutics targeting specific diseases. RyboDyn generates revenue through strategic partnerships and B2B transactions primarily with research institutions and pharmaceutical companies requiring advanced proteomic solutions.
Who invested in RyboDyn
6 investors across 1 round
See all investors in RyboDyn
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 24, 2026
Amount
$10M
Investors
Questions about RyboDyn
Who invested in RyboDyn?
RyboDyn has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RyboDyn raised?
RyboDyn has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RyboDyn last raise money?
RyboDyn's most recent round on record is a Seed, in Mar 2026.
What does RyboDyn do?
Founded in 2022 and based in California, US, RyboDyn, Inc.
Where is RyboDyn headquartered?
RyboDyn is headquartered in San Diego, US.
Which VCs invest in companies like RyboDyn?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RyboDyn's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like RyboDyn? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.